HS-27
Cat. No.:YN371255
| 产品名称: | HS-27 |
| CAS No.: | 1562024-11-6 |
| Chemical Name: | |
| Synonyms: | HS27;HS 27;2-[3-[2-[2-[2-[2-[3-[(3',6'-Dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)carbamothioylamino;2-({21-[(3',6'-Dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthen]-5-yl)amino]-21-thioxo-4,7,10,13,1;HS-27 |
| 分子量: | 993.13 |
| 分子式: | C₅₂H₆₀N₆O₁₂S |
| SMILES: | O=C(N)C1=CC=C(N2N=C(C)C3=C2CC(C)(C)CC3=O)C=C1NCCCOCCOCCOCCOCCOCCCNC(NC4=CC5=C(C6(C7=C(OC8=C6C=CC(O)=C8)C=C(O)C=C7)OC5=O)C=C4)=S |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | HS-27,一种荧光Hsp90抑制剂,检测完整组织标本表面 Hsp90 的表达。HS-27 由 SNX-5422 的核心元素组成,SNX-5422 是一种 Hsp90 抑制剂,通过 PEG 连接物与荧光素衍生物 (异硫氰酸荧光素或 FITC) 连接,后者与外周表达的 Hsp90 结合。HS-27 在乳腺癌的观察与研究中有潜在的应用。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |